Effect of daily alcohol intake on sex hormone levels among postmenopausal breast cancer survivors on aromatase inhibitor therapy: a randomized controlled crossover pilot study.

IF 7.4 1区 医学 Q1 Medicine
Elizabeth Mostofsky, Julie E Buring, Steven E Come, Nadine M Tung, Cancan Zhang, Kenneth J Mukamal
{"title":"Effect of daily alcohol intake on sex hormone levels among postmenopausal breast cancer survivors on aromatase inhibitor therapy: a randomized controlled crossover pilot study.","authors":"Elizabeth Mostofsky, Julie E Buring, Steven E Come, Nadine M Tung, Cancan Zhang, Kenneth J Mukamal","doi":"10.1186/s13058-024-01940-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Alcohol intake is associated with a higher risk of estrogen receptor-positive (ER+) breast cancer (BC), presumably through its confirmed ability to increase sex hormone levels. Whether consuming alcohol within the recommended limit of one serving per day increases sex hormone levels among postmenopausal women taking aromatase inhibitors (AI) to inhibit estrogen production remains unknown. Therefore, we compared sex hormone levels following white wine to levels following white grape juice among ER + BC survivors taking AIs.</p><p><strong>Methods: </strong>In this 10-week randomized controlled two-period crossover trial conducted from September 2022 to July 2023 among 20 postmenopausal women on AIs, we examined within-person changes in sex hormone levels following 3 weeks of 5 ounces of white wine daily versus 3 weeks of 6 ounces of white grape juice daily, with each drinking period preceded by two-week washouts and drinking period sequence allocated by randomization.</p><p><strong>Results: </strong>All 20 participants completed the trial. Compared to daily grape juice, daily wine led to decreases in total estradiol (11.1%, 95%confidence interval[CI] -49.8%,57.2%), free estradiol index (0.7%, 95%CI -2%,0.7%), and free estradiol concentration (7.7%, 95%CI -48%, 63.9%) but increases in estrone (13.8%, 95%CI -9.5%,43.1%), dehydroepiandrosterone sulfate (DHEAS; 11.4%, 95%CI -3.3%,28.4%), and testosterone (12.6%, 95%CI -0.8%,27.7%) and decreased sex hormone-binding globulin (SHBG; -2.7%, 95%CI -21.9%,21.2%).</p><p><strong>Conclusions: </strong>Five ounces of white wine daily did not lead to statistically significant increases in estradiol, but it led to changes in other sex hormones suggesting higher BC risk. Whether this level of alcohol intake diminishes AI effectiveness warrants further investigation.</p><p><strong>Trials registration: </strong>Clinicaltrials.gov NCT05423730 registered June 14, 2022.</p>","PeriodicalId":49227,"journal":{"name":"Breast Cancer Research","volume":"27 1","pages":"5"},"PeriodicalIF":7.4000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720806/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13058-024-01940-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Alcohol intake is associated with a higher risk of estrogen receptor-positive (ER+) breast cancer (BC), presumably through its confirmed ability to increase sex hormone levels. Whether consuming alcohol within the recommended limit of one serving per day increases sex hormone levels among postmenopausal women taking aromatase inhibitors (AI) to inhibit estrogen production remains unknown. Therefore, we compared sex hormone levels following white wine to levels following white grape juice among ER + BC survivors taking AIs.

Methods: In this 10-week randomized controlled two-period crossover trial conducted from September 2022 to July 2023 among 20 postmenopausal women on AIs, we examined within-person changes in sex hormone levels following 3 weeks of 5 ounces of white wine daily versus 3 weeks of 6 ounces of white grape juice daily, with each drinking period preceded by two-week washouts and drinking period sequence allocated by randomization.

Results: All 20 participants completed the trial. Compared to daily grape juice, daily wine led to decreases in total estradiol (11.1%, 95%confidence interval[CI] -49.8%,57.2%), free estradiol index (0.7%, 95%CI -2%,0.7%), and free estradiol concentration (7.7%, 95%CI -48%, 63.9%) but increases in estrone (13.8%, 95%CI -9.5%,43.1%), dehydroepiandrosterone sulfate (DHEAS; 11.4%, 95%CI -3.3%,28.4%), and testosterone (12.6%, 95%CI -0.8%,27.7%) and decreased sex hormone-binding globulin (SHBG; -2.7%, 95%CI -21.9%,21.2%).

Conclusions: Five ounces of white wine daily did not lead to statistically significant increases in estradiol, but it led to changes in other sex hormones suggesting higher BC risk. Whether this level of alcohol intake diminishes AI effectiveness warrants further investigation.

Trials registration: Clinicaltrials.gov NCT05423730 registered June 14, 2022.

每日酒精摄入量对芳香酶抑制剂治疗绝经后乳腺癌幸存者性激素水平的影响:一项随机对照交叉先导研究
背景:酒精摄入与雌激素受体阳性(ER+)乳腺癌(BC)的高风险相关,可能是通过其已证实的增加性激素水平的能力。对于服用芳香酶抑制剂(AI)来抑制雌激素产生的绝经后妇女来说,在每天一份的推荐限度内饮酒是否会增加性激素水平仍不清楚。因此,我们比较了ER + BC幸存者服用AIs后饮用白葡萄酒和喝白葡萄汁后的性激素水平。方法:在这项为期10周的随机对照两期交叉试验中,从2022年9月到2023年7月,在20名患有AIs的绝经后妇女中进行,我们检查了3周每天5盎司白葡萄酒和3周每天6盎司白葡萄汁后性激素水平的变化,每个饮酒期之前都有两周的洗脱期和随机分配的饮酒期顺序。结果:20名受试者全部完成试验。与每日饮用葡萄汁相比,每日饮用葡萄酒导致总雌二醇(11.1%,95%可信区间[CI] -49.8%,57.2%)、游离雌二醇指数(0.7%,95%CI -2%,0.7%)和游离雌二醇浓度(7.7%,95%CI -48%, 63.9%)降低,但雌酮(13.8%,95%CI -9.5%,43.1%)、硫酸脱氢表雄酮(DHEAS;11.4%, 95%CI -3.3%,28.4%),睾酮(12.6%,95%CI -0.8%,27.7%)和性激素结合球蛋白(SHBG;-2.7%, 95%ci -21.9%,21.2%)。结论:每天喝5盎司的白葡萄酒不会导致雌二醇的显著增加,但会导致其他性激素的变化,这表明患乳腺癌的风险更高。这种水平的酒精摄入是否会降低人工智能的有效性还有待进一步调查。试验注册:Clinicaltrials.gov NCT05423730于2022年6月14日注册。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.00
自引率
0.00%
发文量
76
审稿时长
12 weeks
期刊介绍: Breast Cancer Research, an international, peer-reviewed online journal, publishes original research, reviews, editorials, and reports. It features open-access research articles of exceptional interest across all areas of biology and medicine relevant to breast cancer. This includes normal mammary gland biology, with a special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal covers preclinical, translational, and clinical studies with a biological basis, including Phase I and Phase II trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信